Former Spectranetics (NSDQ:SPNC) CEO John Schulte faces up to 5 years in prison and up to $250,000 in fines after a federal jury in Colorado convicted him on a single count of lying to federal investigators about his role in charges that the company illegally imported laser medical devices for a clinical trial.
The jury acquitted Schulte of 11 other charges including conspiracy to defraud the federal government.
Spectranetics agreed to pay $5 million and admitted responsibility late in 2009 to settle its portion of the case, after federal agents raided its Colorado Springs headquarters in 2008. Schulte resigned a few weeks after the raid and was indicted in 2010, along with 3 other defendants – former vice president of business development Obinna "Larry" Adhigije, former business development manager Trung Pham and consultant Hernan Ricuarte.
Pham was acquitted of the 5 charges against him, including conspiring to defraud the federal government and smuggling unapproved medical devices into the country, according to the Colorado Springs Gazette. Adighije’s trial on 5 charges is pending, according to the newspaper, and Ricuarte pleaded guilty in August to a single count of concealing a felony. He faces between 3 months of probation and 6 months in prison and between $250 and $250,000 in fines. He’s slated to be sentenced after all related cases are settled; Schulte is scheduled for a sentencing hearing May 29.
"I’m delighted I was acquitted on all significant counts. It makes me very happy," he told the Gazette. "We will see what we can do to fight the 1 guilty count. I don’t believe the jury got that 1 right. I am very pleased with the outcome. They charged me with some very significant counts. I always tried to do what was best for Spectranetics.
"What happened in 2008 was a very unfortunate situation. I am glad there was resolution in this case. I remain passionate about Spectranetics technology and am rooting for everyone there every step of the way," Schulte said.
NuVasive to move "promptly" on appeal of $101M Medtronic loss
NuVasive (NSDQ:NUVA) said it plans to "promptly" file an appeal of its $101 million patent loss to Medtronic (NYSE:MDT), even as it waits for the U.S. District Court for Southern California to rule on what royalties it owes for the post-verdict period, whether it owes pre-judgment interest and whether it will be made to set aside the amount of then judgment during its appeal. Read more
Align Technology goes after Chinese competitor
Align Technology (NSDQ:ALGN) filed a complaint with the U.S. International Trade Commission accusing a Pakistani firm, ClearCorrect, and its U.S. affiliate of importing data sets used to make braces that infringe patents covering its Invisalign transparent orthodontic mouthpieces. Read more
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.